Process Development Associate - Upstream Cell Culture
Regeneron Pharmaceuticals
Summary
Regeneron's Cell Culture Development Group within Preclinical Manufacturing and Process Development (PMPD) is looking for a motivated Process Development Associate to work as part of the late-stage team to develop production processes of antibodies in a non-GMP process development laboratory. In this lab-based role, they will perform studies at bench scale in support of clinical or commercial manufacturing production.
Job description
When & Where
Location: Tarrytown, New York. Travel: This position requires work on weekends and occasional travel to upstate NY for onsite tech transfer support.
What You'll Do
- Designing and executing cell culture studies in glass bench scale bioreactors (2L to 15L scale) and single-use bioreactors (including AMBR250 system)
- Operating and maintaining bioreactor and analytical equipment, preparing media and feed, performing laboratory tasks with proper aseptic technique
- Generating, analyzing, and managing data in a highly organized manner with a critical mindset
- Conducting statistical data analysis
- Collaborating with colleagues within the late stage cell culture team to complete lab work efficiently
- Collaborating with other groups involved in the research process, including cell line development, bioreactor scale-up, purification, analytics, and manufacturing
- Authoring development reports, electronic lab notebook entries, and process transmittals
Let's Find Out If We're a Fit
- Strong initiative and drive to complete time critical and high-priority tasks efficiently
- Technical and analytical attitude that can learn and understand complex workflows
- Work both independently and collaboratively
- Strong time management skills and can balance multiple priorities simultaneously
- Contribute to lab equipment maintenance and safety to help create a safe, effective and efficient working environment
- Enjoy working with your hands in a wet lab environment
- Possess strong organizational, communication, analytical, computer, and technical writing skills
- Foundation of basic scientific/engineering knowledge obtained through academic training and/or experience
This role requires a BS in Chem Engineering or Bio-related Engineering with 0-2 of experience in a laboratory setting (PDA).
Requirements
- BS in Chemical Engineering or Bio-related Engineering
- 0-2 years of experience in a laboratory setting
- Cell culture study design and execution
- Experience with glass bench scale bioreactors (2L to 15L) and single-use bioreactors (including AMBR250)
- Bioreactor and analytical equipment operation and maintenance
- Media and feed preparation
- Aseptic technique
- Data generation, analysis, and management
- Statistical data analysis
- Technical writing (development reports, ELN entries, process transmittals)
- Strong organizational, communication, analytical, and computer skills
- Ability to work independently and collaboratively
- Strong time management and ability to balance multiple priorities
- Wet lab hands-on work
Benefits
- Student Loan Paydown Program
- Tuition Reimbursement
- Family Care Benefits
- Relocation Assistance
- Inclusion, Culture & Well-Being Programs
- Health and Wellness Programs
- Fitness Centers
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Life and Disability Insurance
- Paid Time Off
- 401(k) Company Match
- Pension or Retirement Benefits
- Annual Bonuses or Incentive Plans
- Equity Awards
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.